Goldman Sachs Group Inc Zai Lab LTD Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 251,507 shares of ZLAB stock, worth $6.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
251,507
Previous 295,959
15.02%
Holding current value
$6.76 Million
Previous $5.13 Million
18.39%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ZLAB
# of Institutions
121Shares Held
46.7MCall Options Held
223KPut Options Held
588K-
Janus Henderson Group PLC London, X08.76MShares$236 Million0.11% of portfolio
-
Wellington Management Group LLP Boston, MA8.44MShares$227 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA6.44MShares$173 Million0.02% of portfolio
-
Viking Global Investors LP1.95MShares$52.4 Million0.18% of portfolio
-
Bamco Inc New York, NY1.91MShares$51.3 Million0.13% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.63B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...